Identifying the Intergenic ALK Fusion LOC388942‐ALK as a Driver of Non–Small Cell Lung Cancer
ABSTRACT ALK fusions, such as the classic EML4‐ALK, are known drivers of lung cancer and effective therapeutic targets. However, variant ALK fusions, including intergenic fusions like LOC388942‐ALK (LA), have been detected in increasing numbers of patients, with their roles in tumorigenesis and ALK...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | MedComm |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.70154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|